Albuterol Sulfate Solution
Product Images NDC 64980-642

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 64980-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Percent Incident Of Adverse Reaction (Percent Incident Of Adverse Reaction)

Percent Incident Of Adverse Reaction (Percent Incident Of Adverse Reaction)
A data table listing the percent incidence of adverse reactions for Albuterol Sulfate involving 135 subjects. Reactions are categorized by system including central nervous system, gastrointestinal, ear/nose/throat, cardiovascular, and respiratory, with specific conditions such as tremors, nausea, nasal congestion, tachycardia, and bronchospasm, along with their corresponding incidence percentages.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Albuterol Sulfate including the phenol ring, side chains, and sulfate ion as part of the molecule.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
An instructional illustration showing a person using a respiratory inhalation device, demonstrating correct inhaler technique with the inhaler directed towards the mouth.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
An instructional illustration showing a hand dropping liquid from a dropper onto a folded piece of paper or item, likely demonstrating the correct method to apply or use the product solution.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
An illustration showing the use of a respiratory inhalation device with a mouthpiece connected to a container, demonstrating how to position or operate the device for inhalation of Albuterol Sulfate solution.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
Illustration showing a person using an inhalation device, demonstrating the proper technique by placing the mouthpiece in the mouth to inhale the medication.*
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
Albuterol Inhalation Solution, USP 0.5% 2.5 mg/0.5 mL sterile solution for oral inhalation, packaged as one 0.5 mL unit-of-use vial. The label includes dosage instructions, storage conditions (20°C to 25°C), and manufacturer details for Rising Pharma Holdings, Inc. NDC 64980-642-03.*
FDA Label Image

Figure 6 (Figure 6)

Figure 6 (Figure 6)
Packaging label for Albuterol Sulfate Inhalation Solution USP 0.5%, with strength 2.5 mg/0.5 mL, for respiratory inhalation use. The label includes manufacturer information as Rising Pharma Holdings, Inc., and indicates a package size of 30 x 0.5 mL unit dose vials. The design features blue panels with white text and includes usage and adverse reaction information.*
FDA Label Image

Figure 7 (Figure 7)

Figure 7 (Figure 7)
Packaging label for Albuterol Sulfate Inhalation Solution USP 0.65% (2.5 mg/.5 mL) by Rising Pharma Holdings, Inc. The flat label layout includes detailed product information panels and fold lines for assembly. It is intended for respiratory inhalation use and includes multiple safety and usage panels marked with 'NO INK OR QA' warnings for print alignment.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.